Search Page

1

Cite

Share

Applications of nanoparticles for diagnosis and therapy of cancer.

Baetke SC, Lammers T, Kiessling F. Baetke SC, et al. Among authors: kiessling f. Br J Radiol. 2015 Oct;88(1054):20150207. doi: 10.1259/bjr.20150207. Epub 2015 Jun 12. Br J Radiol. 2015. PMID: 25969868 Free PMC article. Review.

Cite

Share

2

Cite

Share

Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Dadfar SM, Roemhild K, Drude NI, von Stillfried S, Knüchel R, Kiessling F, Lammers T. Dadfar SM, et al. Among authors: kiessling f. Adv Drug Deliv Rev. 2019 Jan 1;138:302-325. doi: 10.1016/j.addr.2019.01.005. Epub 2019 Jan 11. Adv Drug Deliv Rev. 2019. PMID: 30639256 Free PMC article. Review.

Cite

Share

3

Cite

Share

Smart cancer nanomedicine.

van der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJM, Lammers T. van der Meel R, et al. Among authors: kiessling f. Nat Nanotechnol. 2019 Nov;14(11):1007-1017. doi: 10.1038/s41565-019-0567-y. Epub 2019 Nov 6. Nat Nanotechnol. 2019. PMID: 31695150 Free PMC article.

Cite

Share

4

Cite

Share

Tumor targeting via EPR: Strategies to enhance patient responses.

Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, Lammers T. Golombek SK, et al. Among authors: kiessling f. Adv Drug Deliv Rev. 2018 May;130:17-38. doi: 10.1016/j.addr.2018.07.007. Epub 2018 Jul 19. Adv Drug Deliv Rev. 2018. PMID: 30009886 Free PMC article. Review.

Cite

Share

5

Cite

Share

Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma.

Hage C, Hoves S, Strauss L, Bissinger S, Prinz Y, Pöschinger T, Kiessling F, Ries CH. Hage C, et al. Among authors: kiessling f. Hepatology. 2019 Oct;70(4):1280-1297. doi: 10.1002/hep.30666. Epub 2019 May 21. Hepatology. 2019. PMID: 31002440

Cite

Share

6

Cite

Share

Dexamethasone nanomedicines for COVID-19.

Lammers T, Sofias AM, van der Meel R, Schiffelers R, Storm G, Tacke F, Koschmieder S, Brümmendorf TH, Kiessling F, Metselaar JM. Lammers T, et al. Among authors: kiessling f. Nat Nanotechnol. 2020 Aug;15(8):622-624. doi: 10.1038/s41565-020-0752-z. Nat Nanotechnol. 2020. PMID: 32747742 Free PMC article. No abstract available.

Cite

Share

7

Cite

Share

Cancer nanomedicine meets immunotherapy: opportunities and challenges.

Sun Q, Bai X, Sofias AM, van der Meel R, Ruiz-Hernandez E, Storm G, Hennink WE, De Geest B, Kiessling F, Yu HJ, Lammers T, Shi Y. Sun Q, et al. Among authors: kiessling f. Acta Pharmacol Sin. 2020 Jul;41(7):954-958. doi: 10.1038/s41401-020-0448-9. Epub 2020 Jun 17. Acta Pharmacol Sin. 2020. PMID: 32555445 Free PMC article. Review.

Cite

Share

8

Cite

Share

MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1.

Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H, Hristov M, Wang S, Kiessling F, Olson EN, Weber C. Schober A, et al. Among authors: kiessling f. Nat Med. 2014 Apr;20(4):368-76. doi: 10.1038/nm.3487. Epub 2014 Mar 2. Nat Med. 2014. PMID: 24584117 Free PMC article.

Cite

Share

9

Cite

Share

Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer.

Fiegle E, Doleschel D, Koletnik S, Rix A, Weiskirchen R, Borkham-Kamphorst E, Kiessling F, Lederle W. Fiegle E, et al. Among authors: kiessling f. Neoplasia. 2019 Sep;21(9):932-944. doi: 10.1016/j.neo.2019.07.006. Epub 2019 Aug 11. Neoplasia. 2019. PMID: 31412307 Free PMC article.

Cite

Share

10

Cite

Share

Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug Vesicles.

Wang B, Van Herck S, Chen Y, Bai X, Zhong Z, Deswarte K, Lambrecht BN, Sanders NN, Lienenklaus S, Scheeren HW, David SA, Kiessling F, Lammers T, De Geest BG, Shi Y. Wang B, et al. Among authors: kiessling f. J Am Chem Soc. 2020 Jul 15;142(28):12133-12139. doi: 10.1021/jacs.0c01928. Epub 2020 Jun 30. J Am Chem Soc. 2020. PMID: 32524819 Free PMC article.

Cite

Share